RE: Chef27 Feb 2019 19:19
Trying to figure this out
RNS Number : 0444N
Midatech Pharma PLC
03 May 2018
3 May 2018
Midatech Pharma PLC
("Midatech" or the "Company")
Midatech Announces Receipt of NASDAQ Notice
Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising products in oncology and immunotherapy, announced today that it received written notification (the "Notification Letter") from The NASDAQ Stock Market LLC ("NASDAQ"), dated 1 May 2018, stating that the Company is not in compliance with the minimum bid price requirement set forth in NASDAQ's rules for continued listing on The NASDAQ Capital Market. NASDAQ Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the Company's American Depositary Shares (the "Depositary Shares"), each representing two ordinary shares of the Company, for the 30 consecutive business days beginning March 19, 2018, the Company no longer meets the minimum bid price requirement.